Connect with us
The company has offices in Madrid, Barcelona and Mexico, the latter covering several Latin American countries. To date, iDoctus has invested $5.9 million (€5 million) in...
Clinicas Mi is a group of clinics of Catalan origin, owned by the Masfurroll family, a surname with a long tradition in Spanish healthcare. At the...
This summer, Exheus has received an Enisa loan amounting to $236,000 (€200,000). This is a long-term loan issued by the Ministry and offers extended repayment and...
ExeVir is a spin-off of VIB and is headed by German Dr. Torsten Mummenbrauer, a virologist who has worked for GSK Morphosys, Hookipa Pharma and Velvio....
Grifols has assured that 87.93% of bondholders of its secured bonds, 81.01% of unsecured bonds, the required 93.82% of underwriters of its syndicated credit facility, and...
Valneva will soon be able to sell its Covid-19 vaccine candidate. On the European side, Valneva has broken off negotiations with the European Commission, preferring bilateral...
Before being authorized, the vaccine developed by Hipra will have to pass stage I/II, where its safety will have to be demonstrated. Phase III will then...
Gilead's peak revenue in Spain was in 2015 when the company had a turnover $1.15 billion (€978.5 million). Those figures were due to the commercialization of...
The biotech company Sinovac announced that it plans to build a vaccine manufacturing facility in Chile. Minister of Health, Enrique Paris, also detailed that the vaccines...
Incliva participates in the $6.2 million (€5.2 million) European Rebecca project to address the post-treatment of breast cancer. The project will end in March 2025 and...
 |
|
 |  |
 |
|